Both gender and concurrent chronic lymphocytic thyroiditis may influence the nuclear texture of papillary thyroid carcinomas cells

References

• Yu GP, Li JC, Branovan D, et al. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 2010;20:465–73
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 2010;34:28–35
   PubMed Web of Science ®Google Scholar
• Kilfoy BA, Devesa SS, Ward MH, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;18:1092–100
   Web of Science ®Google Scholar
• Zeng Q, Chen GG, Vlantis AC, van Hasselt CA. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 2007;40:921–35
   PubMed Web of Science ®Google Scholar
• Tavangar SM, Monajemzadeh M, Larijani B, Haghpanah V. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Med J 2007;48:744–7
   Google Scholar
• Ward LS, Assumpcao LV. The impact of gender in differentiated thyroid cancer. Clin Endocrinol (Oxf) 2007;66:752–3
   Google Scholar
• Chen GG, Vlantis AC, Zeng Q, van Hasselt CA. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 2008;8:367–77
   PubMedGoogle Scholar
• Rukhman N, Silverberg A. Thyroid cancer in older men. Aging Male 2011;14:91–8
   Web of Science ®Google Scholar
• Libutti SK. Understanding the role of gender in the incidence of thyroid cancer. Cancer J 2005;11:104–5
   PubMed Web of Science ®Google Scholar
• Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 2009;115:3801–7
   PubMed Web of Science ®Google Scholar
• Machens A, Hauptmann S, Dralle H. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clin Endocrinol (Oxf) 2006;65:500–5
   PubMed Web of Science ®Google Scholar
• Thiruvengadam A, Govindarajulu P, Aruldhas MM. Modulatory effect of estradiol and testosterone on the development of N-nitrosodiisopropanolamine induced thyroid tumors in female rats. Endocr Res 2003;29:43–51
   PubMed Web of Science ®Google Scholar
• Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol 2010;6:1771–9
   PubMed Web of Science ®Google Scholar
• Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 2010;21:149–53
   Google Scholar
• Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001;25:632–7
   PubMed Web of Science ®Google Scholar
• Loh KC, Greenspan FS, Dong F, et al. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999;84:458–63
   PubMed Web of Science ®Google Scholar
• Kavanagh DO, McIlroy M, Myers E, et al. The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2. Endocr Relat Cancer 2010;17:255–64
   Google Scholar
• Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955;70:291–7
   PubMedGoogle Scholar
• Cunha LL, Ferreira RC, Marcello MA, et al. Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011;2011:387062
   PubMedGoogle Scholar
• Adam RL, Silva RC, Pereira FG, et al. The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol 2006;28:55–9
   PubMed Web of Science ®Google Scholar
• Ferreira RC, Ward LS, Adam RL, et al. Contribution of nuclear texture analysis for the differential diagnosis of follicular lesions of the thyroid: comparison to immunohistochemical markers. Arq Bras Endocrinol Metabol 2009;53:804–10
   Google Scholar
• Doudkine A, Macaulay C, Poulin N, Palcic B. Nuclear texture measurements in image cytometry. Pathologica 1995;87:286–99
   PubMedGoogle Scholar
• Adam RL, Leite NJ, Metze K. Image preprocessing improves Fourier-based texture analysis of nuclear chromatin. Anal Quant Cytol Histol 2008;30:175–84
   Google Scholar
• Metze K, Adam RL, Vido JR, Lorand-Metze IG. The influence of staining characteristics on nuclear texture features in cytology. Anal Quant Cytol Histol 2009;31:241–6
   PubMedGoogle Scholar
• Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803
   PubMed Web of Science ®Google Scholar
• Cunha LL, Ward LS. Concurrent lymphocytic thyroiditis is associated to less aggressive papillary thyroid carcinomas. Eur Arch Otorhinolaryngol 2012;269:699–700
   Google Scholar
• Cunha LL, Ward LS. Comments on “well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence". Endocr Pathol 2011;22:172–3
   Google Scholar
• Knezevic-Obad A, Knezevic Stromar I. Cytomorphological characteristics of thyroid papillary carcinoma and their prognostic value. Acta Med Croatica 2008;62:365–71
   Google Scholar
• Ferreira RC, de Matos PS, Adam RL, et al. Application of the Minkowski-Bouligand fractal dimension for the differential diagnosis of thyroid follicular neoplasias. Cell Oncol 2006;28:331–3
   PubMed Web of Science ®Google Scholar
• Bedin V, Adam RL, de Sa BC, et al. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. BMC Cancer 2010;10:260
   PubMed Web of Science ®Google Scholar
• West LA, Swartz R, Cox D, et al. Cytometric features of cell nuclei of adenocarcinoma in situ and invasive adenocarcinoma of the cervix. Am J Obstet Gynecol 2002;187:1566–73
   Google Scholar
• Rajoria S, Suriano R, Shanmugam A, et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010;20:33–41
   PubMed Web of Science ®Google Scholar
• Chen GG, Zeng Q, Tse GM. Estrogen and its receptors in cancer. Med Res Rev 2008;28:954–74
   PubMed Web of Science ®Google Scholar
• Pageau GJ, Hall LL, Ganesan S, et al. The disappearing Barr body in breast and ovarian cancers. Nat Rev Cancer 2007;7:628–33
   Google Scholar